Conference call to discuss financial results and recent business highlights to take place on Wednesday, August 28, 2024 , at 8:00 AM ET ROCKVILLE, Md. , Aug. 14, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB ) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to host a conference call and webcast on Wednesday, August 28, 2024 , 8:00 AM ET to discuss financial results, pipeline progress and recent business highlights for the half year ended June 30, 2024 .
I-Mab Conference Call and Webcast Information : Investors and analysts are invited to join the conference call at 8:00 AM ET on August 28, 2024 , via: Domestic Dial-in : 1-877-407-0784 International Dial-in : 1-201-689-8560 Conference ID : 13747695 Webcast : please click here Note that Participants can use Guest dial-in #s above and be answered by an operator OR click the Call meTM link for instant telephone access to the event. The Call meTM link will be made active 15 minutes prior to the scheduled start time. A webcast of the call will also be available on the I-Mab website , on the Upcoming Events section of the Investor Relations page , available by clicking here .
A replay of the call will be accessible under the Past Events section of the Investor Relations page and will be archived for 6 months. About I-Mab I-Mab (NASDAQ: IMAB ) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville , Maryland.
For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X .
I-Mab Contacts SOURCE I-Mab Biopharma.
